Eton Pharmaceuticals Inc (ETON)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Eton Pharmaceuticals Inc-Aktie (ETON)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	18.65% 22.46	18.93	17.28	11.65	10.32
Cost Of Revenue	108.51% 14.60	7.004	7.421	5.171	4.022
Gross Profit	34.12% 7.855	11.92	9.861	6.476	6.302
Operating Expenses	31.20% 9.218	13.40	10.33	5.847	5.793
Interest Income/Expense	1.17% 1.212	1.198	1.163	-	0.211
Benefits Costs and Expenses	13.83% 24.41	21.45	18.78	12.16	9.823
Costs And Expenses	13.83% 24.41	21.45	18.78	12.16	9.823
Depreciation and Amortization	0.40% 1.009	1.005	1.013	0.355	0.278
Operating Income/Loss	7.59% -1.363	-1.475	-0.47	0.629	0.509
Income/Loss From Continuing Operations Before Tax	22.39% -1.955	-2.519	-1.498	-0.511	0.501
Income Tax Expense/Benefit	142.42% -0.028	0.066	0.074	0.087	-0.126
Income/Loss From Continuing Operations After Tax	25.45% -1.927	-2.585	-1.572	-0.598	0.627
Net Income/Loss	25.45% -1.927	-2.585	-1.572	-0.598	0.627
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.00% 26.89	26.89	26.89	25.87	0.0259
Diluted Average Shares	26.89	-	-	-	0.0266
Basic Earnings Per Share	30.00% -0.07	-0.10	-0.06	-0.03	0.02
Diluted Earnings Per Share	-0.07	-	-	-	0.02
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ELAN

$22.94

1.15%

RGC

$23.23

3.21%

RDY

$14.13

1.53%

NBIX

$129.78

1.57%

VTRS

$13.51

2.10%

UTHR

$536.12

0.62%